Tag: CTx-648
Drug candidate offers hope for ER-positive breast cancer patients
An international research collaboration, spearheaded by Pfizer in partnership with Monash University and the Cancer Therapeutics Cooperative Research Centre in Australia, has identified a promising pre-clinical drug candidate with potential anti-tumour activity against Estrogen Receptor (ER) positive breast cancer.
Featured Article
APS Industrial brings Siemens’ next-gen PLC to Aussie manufacturers
As the manufacturing industry advances towards greater automation and digitalisation, companies are seeking smarter and more efficient control solutions to enhance their operations.
